squidd the two big delayed reporting buys early in the morning (shown as 150K sells as reported after the move up) is what pushed it up, followed by a 25K sell at mid price. Very short of stock here and any large buy is pushing it up more and we are still due more news on holdings increases in my opinion this week.
Melatonin is starting to appear on hospital prescription sheets especially in the area of Dementia. It does not appear in the BNF (British national formulary)the last time i looked as it is not licensed.What makes that OK i dont know but I will enquire.It seems to work especially in this difficult client group. Benzodiazipines and other sedatives are really useless after a while. If a natural remedy could be used frequently without gradual resistence it would make my job a lot easier and has been suggested here a huge pharmalogical money maker. Frodo
Could well be a bid coming ! I say this as Nigel Wray took up over 3 million of those 19 million buys @15p from Wednesday last week, but we still have not heard anything of the other 16 million and who purchased them on the same day. No news on holdings and we could be looking at a bid here !
PpP: Have returned to find bright blue blossom covering APH and my holding now shows a 40% gain since buying only about 6 weeks ago. Would be tempted to add were there any retraction, but bid or no, this one now seems to have a real head of steam and I am looking forward to a profitable ride.
Meanwhile, my own low key enquiries among medics about Melatonin point the same way as that reported by frodo, so here's to Posidorm.
I do like your headers, which I note have spread to others of your favourites and which I continue to monitor.
sd.
squidd it does look good on the APH front. VLK is rumoured to be about to release loads of contract news next week and could be going to 45p or higher. Today UNG gave a good solid trading statement and is one to watch in the coming months for solid gains.
squidd are you still on holiday ? What do you think of the Hardman write up ? In my opinion Periostat will do better this year than they forecast and Posiderm will be massive for the future.